載入中
Toho Holdings Co., Ltd. serves as a leading wholesaler of pharmaceutical and healthcare products throughout Japan. Its extensive product range includes prescription and over-the-counter medications, reagents, medical devices and supplies, and health foods, in addition to offerings for preventive, clinical, community, and home-based medical and nursing care. Beyond distribution, the company provides comprehensive support services like developing and selling customer-focused software, assisting with the establishment of new medical facilities and pharmacies, delivering management consulting, offering medical assistance, and facilitating personnel recruitment. Toho Holdings also operates dispensing pharmacies, manufactures and distributes generic drugs, acts as a site management organization (SMO) to support clinical trials for various healthcare institutions, and supplies specialized software to the medical sector. Among its technological solutions are customer support systems such as ENIF for pharmaceutical ordering, ENI-Pharmacy for streamlining dispensing and prescribing processes, LXMATE HeLios for medical appointments, KAITOS for online medical consultations and medication guidance, ENIFwin for inventory control in large hospitals, the ENIFvoice series for voice-activated electronic medication history recording, and ENIF Nurse for home-visit nurse operational support, along with diverse logistics systems. The company, founded in 1948, is headquartered in Tokyo, Japan.
最新資料
¥3,968
+¥281 · +7.62%
盤中時間採用JST。市場資料可能有所延遲。
Toho Holdings Co., Ltd. serves as a leading wholesaler of pharmaceutical and healthcare products throughout Japan. Its extensive product range includes prescription and over-the-counter medications, reagents, medical devices and supplies, and health foods, in addition to offerings for preventive, clinical, community, and home-based medical and nursing care. Beyond distribution, the company provides comprehensive support services like developing and selling customer-focused software, assisting with the establishment of new medical facilities and pharmacies, delivering management consulting, offering medical assistance, and facilitating personnel recruitment. Toho Holdings also operates dispensing pharmacies, manufactures and distributes generic drugs, acts as a site management organization (SMO) to support clinical trials for various healthcare institutions, and supplies specialized software to the medical sector. Among its technological solutions are customer support systems such as ENIF for pharmaceutical ordering, ENI-Pharmacy for streamlining dispensing and prescribing processes, LXMATE HeLios for medical appointments, KAITOS for online medical consultations and medication guidance, ENIFwin for inventory control in large hospitals, the ENIFvoice series for voice-activated electronic medication history recording, and ENIF Nurse for home-visit nurse operational support, along with diverse logistics systems. The company, founded in 1948, is headquartered in Tokyo, Japan.
日內區間
目前¥3,968
52週區間
目前¥3,968
盤中時間採用JST。市場資料可能有所延遲。
Toho Holdings Co., Ltd. serves as a leading wholesaler of pharmaceutical and healthcare products throughout Japan. Its extensive product range includes prescription and over-the-counter medications, reagents, medical devices and supplies, and health foods, in addition to offerings for preventive, clinical, community, and home-based medical and nursing care. Beyond distribution, the company provides comprehensive support services like developing and selling customer-focused software, assisting with the establishment of new medical facilities and pharmacies, delivering management consulting, offering medical assistance, and facilitating personnel recruitment. Toho Holdings also operates dispensing pharmacies, manufactures and distributes generic drugs, acts as a site management organization (SMO) to support clinical trials for various healthcare institutions, and supplies specialized software to the medical sector. Among its technological solutions are customer support systems such as ENIF for pharmaceutical ordering, ENI-Pharmacy for streamlining dispensing and prescribing processes, LXMATE HeLios for medical appointments, KAITOS for online medical consultations and medication guidance, ENIFwin for inventory control in large hospitals, the ENIFvoice series for voice-activated electronic medication history recording, and ENIF Nurse for home-visit nurse operational support, along with diverse logistics systems. The company, founded in 1948, is headquartered in Tokyo, Japan.
日內區間
目前¥3,968
52週區間
目前¥3,968
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目（JPY） | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 1.55兆 JPY | 1.52兆 JPY | 1.48兆 JPY | 1.39兆 JPY | 1.27兆 JPY |
| 銷貨成本 | 1.44兆 JPY | 1.4兆 JPY | 1.36兆 JPY | 1.28兆 JPY | 1.16兆 JPY |
| 毛利 | 1167.51億 JPY | 1159.99億 JPY | 1129.85億 JPY | 1047.54億 JPY | 1022.77億 JPY |
| 研究與開發 | — | 2.99億 JPY | 4.45億 JPY | — | — |
| 銷售、一般及管理費用 | 908.7億 JPY | 879.02億 JPY | 844.24億 JPY | 835.26億 JPY | 814.33億 JPY |
| 營業費用 | 1004.29億 JPY | 972億 JPY | 938.02億 JPY | 919.39億 JPY | 897.49億 JPY |
| 利息收入 | 1.92億 JPY | 9300萬 JPY | 5800萬 JPY | 5800萬 JPY | 6400萬 JPY |
| 利息支出 | 5600萬 JPY | 4600萬 JPY | 1.45億 JPY | 7200萬 JPY | 7600萬 JPY |
| 折舊和攤銷 | 61.6億 JPY | 60.79億 JPY | 65.14億 JPY | 64.13億 JPY | 69.57億 JPY |
| 營業利益 | 163.22億 JPY | 187.99億 JPY | 191.83億 JPY | 128.15億 JPY | 125.28億 JPY |
| 淨利 | 173.28億 JPY | 198.44億 JPY | 206.57億 JPY | 136.31億 JPY | 133.8億 JPY |
公司資料更新於 2026年10月13日。
近期已公布業績
近期已公布業績
年度分割調整後的每股現金分配。
¥85.00
2025年（完整年度）+183.3% 自從 2021
2026年（部分年度）：¥210
¥30.00
2,021
¥31.00
2,022
¥34.00
2,023
¥47.00
2,024
¥85.00
2,025
¥210
2,026*
* 在現有股息歷史記錄中，該日曆年僅包含部分期間。
| 行動 | 除息日 | 詳情 | 記錄日期 | 付款日期 |
|---|---|---|---|---|
股息即將實施 | 2027年3月30日 | ¥90.00Semi-Annual | 2027年3月31日 | 2027年3月30日 |
股息 | 2026年9月29日 | ¥90.00Semi-Annual | 2026年9月30日 | 2026年9月29日 |
股息 | 2026年3月30日 | ¥120Semi-Annual | 2026年3月31日 | 2026年6月5日 |
股息 | 2025年9月29日 | ¥45.00Semi-Annual | 2025年9月30日 | 2025年12月1日 |
股息 | 2025年3月28日 | ¥40.00Semi-Annual | 2025年3月31日 | 2025年6月6日 |
股息 | 2024年9月27日 | ¥25.00Annual | 2024年9月30日 | 2024年12月2日 |
除息 2027年3月30日
¥90.00
Semi-Annual
2027年3月31日登記 · 支付日 2027年3月30日
除息 2026年9月29日
¥90.00
Semi-Annual
2026年9月30日登記 · 支付日 2026年9月29日
除息 2026年3月30日
¥120
Semi-Annual
2026年3月31日登記 · 支付日 2026年6月5日
除息 2025年9月29日
¥45.00
Semi-Annual
2025年9月30日登記 · 支付日 2025年12月1日
除息 2025年3月28日
¥40.00
Semi-Annual
2025年3月31日登記 · 支付日 2025年6月6日
除息 2024年9月27日
¥25.00
Annual
2024年9月30日登記 · 支付日 2024年12月2日
報告持有此股票曝險的交易所交易基金。
NEXT FUNDS TOPIX Exchange Traded Fund1306.T71.84億0.02%35.13兆 JPY0.05%¥432.1-0.09%
iShares Core TOPIX ETF1475.T5.72億0.02%3.01兆 JPY0.05%¥425.4-0.05%
Vanguard Total International Stock ETFVXUS1947.59萬0.00%6657億 USD0.05%US$84.435-0.45%
Vanguard FTSE Developed Markets ETFVEA1371.19萬0.00%3238億 USD0.03%US$69.95-0.57%
iShares Core MSCI EAFE ETFIEFA1314.3萬0.01%1894.71億 USD0.07%US$96.18-0.35%
Avantis International Small Cap Value ETFAVDV639.09萬0.03%200.38億 USD0.36%US$108.03-0.45%
Vanguard FTSE All-World ex-US Small-Cap ETFVSS524.27萬0.03%145億 USD0.06%US$154.14-0.63%
iShares MSCI EAFE Small-Cap ETFSCZ450.82萬0.04%128.85億 USD0.40%US$83.62-0.37%NEXT FUNDS TOPIX Exchange Traded Fund1306.TiShares Core TOPIX ETF1475.TVanguard Total International Stock ETFVXUSVanguard FTSE Developed Markets ETFVEAiShares Core MSCI EAFE ETFIEFAAvantis International Small Cap Value ETFAVDVVanguard FTSE All-World ex-US Small-Cap ETFVSSiShares MSCI EAFE Small-Cap ETFSCZAI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
